We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
The recommendations comprise improvement proposals for new drug registrations; animal toxicity and testing, clinical trials; and measures to shape the R&D ecosystem for India pharma sector.